Neovasc Announces FDA Approval of COSIRA-II Clinical Trial

Ads

You May Also Like

ThromboGenics Business Update – FY 2017

Press release                                                          15 March 2018Regulated Information Advancing Preclinical and Clinical Diabetic Eye Disease Portfolio ...